North Coast&s;s capitalization allows them to see a promising venture through all stages of their private funding needs.
Business Model:
Revenue: $11.5M
Employees: 11-50
Address: Suite 201
City: Midland
State: MI
Zip: 48640
Country: US
North Coast&s;s capitalization allows them to see a promising venture through all stages of their private funding needs. Although they co-invest with other venture capital firms, and corporate partners, they are often the first or sole venture investor in the companies they back.
Contact Phone:
+17346627667
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2013 | Delphinus Medical Technologies | Series B | 11M |
2/2014 | VNN | Series A | 0 |
9/2015 | VNN | Venture Round | 0 |
3/2003 | Arbortext | Venture Round | 8.8M |
9/2022 | Delphinus Medical Technologies | Series D | 0 |
7/2010 | Delphinus Medical Technologies | Series A | 8M |
3/2013 | Waymark | Series A | 0 |
12/2017 | Impact Analytical | Venture Round | 0 |
9/2006 | RenaMed Biologics | Venture Round | 0 |
3/2019 | Betterworks | Series B | 0 |
10/2001 | NTT Global Networks | Series B | 35M |
12/2012 | Larky | Seed Round | 650k |
8/2012 | Livio Radio | Series C | - |
6/2014 | Larky | Series A | 1.8M |
5/2000 | ONE (Open Networks Engineering) | Series A | 1.5M |
1/2012 | CytoPherx | Series C | 34M |
10/2007 | CytoPherx | Series A | 2.5M |
9/2015 | Delphinus Medical Technologies | Series C | 0 |
5/2018 | BlueWillow Biologics | Series A | 10M |
3/2019 | Betterworks | Series B | 0 |
5/2018 | BlueWillow Biologics | Series A | 0 |
12/2017 | Impact Analytical | Venture Round | 0 |
9/2015 | Delphinus Medical Technologies | Series C | 0 |
9/2015 | VNN | Venture Round | 0 |
6/2014 | Larky | Series A | 0 |
2/2014 | VNN | Series A | 0 |
9/2013 | Delphinus Medical Technologies | Series B | 0 |
3/2013 | Waymark | Series A | 0 |
12/2012 | Larky | Seed Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|